IMU Biosciences is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Based in the United Kingdom, IMU Biosciences is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
IMU Biosciences develops a high-dimensional immunology platform that measures over 100 million immune data points from a small blood sample to enable precision medicine in areas such as transplantation and immuno-oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.